emergence of a multiply drug resistant enterobacter cloacae during a seven-week period in 1980 caused amikacin to become the aminoglycoside of choice in the initial management of suspected sepsis in a neonatal intensive care unit .
C0002499
amikacin
C0036690
sepsis